美国 · SEC FORM 4
Organogenesis Holdings Inc.
ORGO · Nasdaq · CIK 0001661181 · Healthcare · Drug Manufacturers—Specialty & Generic
内部人信号
当前没有活跃买入信号
0 qualifying P purchase groups
当前 180 天评分窗口
0 同一窗口内观察到的 Form 4 交易行
0 sales · 0 期权、代扣税、授予、赠与或其他交易行
最近一次合资格买入2026-03-09 · Leibowitz Arthur S · $13.4K
为什么没有活跃信号？
买入活动无
近期买入无
近期卖出无
买入信号状态未激活
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
Cluster未计算
买入规模未计算
角色未计算
近期性未计算
确信度未计算
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
当前 180 天窗口内没有 Form 4 交易事件。
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
信号历史
暂无已记录的活跃信号快照
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2026-03-09 · Leibowitz Arthur S.
近期 Form 4 活动
2买入
4卖出
70其他 Form 4 交易行
33SEC 申报 · 365天
买入0 qualifying P line(s) · 180 days
卖出0 sale line(s) · 仅供背景
其他0 exercise / withholding / award / gift / other lines
10b5-1／计划交易Not assessed
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 15,002,130
- 上期报告
- 14,119,761
- 日均成交量
- 563,439
- 回补天数
- 26.6
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-03-09 | Leibowitz Arthur S | 买入 (P) | Class A Common Stock | 5,000 | USD 2.68 | USD 13,400 | SEC 申报 ↗ |
| 2026-03-09 | Driscoll Michael Joseph | 买入 (P) | Class A Common Stock | 10,000 | USD 2.67 | USD 26,700 | SEC 申报 ↗ |
| 2025-06-06 | Freedman Lori | 买入 (P) | Class A Common Stock | 9,022 | USD 2.99 | USD 26,976 | SEC 申报 ↗ |
| 2025-06-05 | Freedman Lori | 买入 (P) | Class A Common Stock | 142,379 | USD 2.91 | USD 414,323 | SEC 申报 ↗ |
| 2025-06-04 | Freedman Lori | 买入 (P) | Class A Common Stock | 100,863 | USD 2.82 | USD 284,434 | SEC 申报 ↗ |
| 2025-05-15 | NUSSDORF GLENN H | 买入 (P) | Class A Common Stock | 107,494 | USD 2.99 | USD 321,407 | SEC 申报 ↗ |
| 2025-05-14 | NUSSDORF GLENN H | 买入 (P) | Class A Common Stock | 251,001 | USD 3.09 | USD 775,593 | SEC 申报 ↗ |
| 2022-11-21 | KATZ MICHAEL W | 买入 (P) | Class A Common Stock | 3,000 | USD 2.56 | USD 7,680 | SEC 申报 ↗ |
| 2022-11-18 | KATZ MICHAEL W | 买入 (P) | Class A Common Stock | 3,000 | USD 2.57 | USD 7,710 | SEC 申报 ↗ |
| 2022-08-12 | Leibowitz Arthur S | 买入 (P) | Class A Common Stock | 3,000 | USD 4.76 | USD 14,280 | SEC 申报 ↗ |
| 2022-08-12 | Driscoll Michael Joseph | 买入 (P) | Class A Common Stock | 5,000 | USD 4.80 | USD 24,000 | SEC 申报 ↗ |
| 2022-05-16 | KATZ MICHAEL W | 买入 (P) | Class A Common Stock | 10,000 | USD 6.03 | USD 60,320 | SEC 申报 ↗ |
| 2021-12-13 | KATZ MICHAEL W | 买入 (P) | Class A Common Stock | 500 | USD 9.65 | USD 4,825 | SEC 申报 ↗ |
| 2021-12-03 | KATZ MICHAEL W | 买入 (P) | Class A Common Stock | 800 | USD 9.35 | USD 7,480 | SEC 申报 ↗ |
| 2021-12-02 | KATZ MICHAEL W | 买入 (P) | Class A Common Stock | 1,800 | USD 9.66 | USD 17,390 | SEC 申报 ↗ |
Form 4 申报证据
76 transaction lines in the latest 365-day window; 433 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-03-09 | Leibowitz Arthur S | 买入 (P) | Class A Common Stock | 5,000 | USD 2.68 | USD 13,400 | SEC 申报 ↗ |
| 2026-03-09 | Driscoll Michael Joseph | 买入 (P) | Class A Common Stock | 10,000 | USD 2.67 | USD 26,700 | SEC 申报 ↗ |
| 2026-03-01 | Cavorsi Robert | 代扣税 (F) | Class A Common Stock | 700 | USD 3.21 | USD 2,247 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-03-09 | Leibowitz Arthur S | 买入 (P) | Class A Common Stock | 5,000 | USD 2.68 | USD 13,400 | SEC 申报 ↗ |
| 2026-03-09 | Driscoll Michael Joseph | 买入 (P) | Class A Common Stock | 10,000 | USD 2.67 | USD 26,700 | SEC 申报 ↗ |
| 2026-03-01 | Cavorsi Robert | 代扣税 (F) | Class A Common Stock | 700 | USD 3.21 | USD 2,247 | SEC 申报 ↗ |
| 2026-02-18 | Montecalvo Antonio S. | 代扣税 (F) | Class A Common Stock | 3,778 | USD 3.84 | USD 14,508 | SEC 申报 ↗ |
| 2026-02-18 | Montecalvo Antonio S. | 奖励／授予 (A) | Class A Common Stock | 11,330 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-18 | Grow Brian | 代扣税 (F) | Class A Common Stock | 11,887 | USD 3.84 | USD 45,646 | SEC 申报 ↗ |
| 2026-02-18 | Grow Brian | 奖励／授予 (A) | Class A Common Stock | 48,818 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-18 | Gillheeney Gary S. | 代扣税 (F) | Class A Common Stock | 91,311 | USD 3.84 | USD 350,634 | SEC 申报 ↗ |
| 2026-02-18 | Gillheeney Gary S. | 奖励／授予 (A) | Class A Common Stock | 188,856 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-18 | Freedman Lori | 代扣税 (F) | Class A Common Stock | 14,411 | USD 3.84 | USD 55,338 | SEC 申报 ↗ |
| 2026-02-18 | Freedman Lori | 奖励／授予 (A) | Class A Common Stock | 43,212 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-18 | Francisco David | 代扣税 (F) | Class A Common Stock | 14,687 | USD 3.84 | USD 56,398 | SEC 申报 ↗ |
| 2026-02-18 | Francisco David | 奖励／授予 (A) | Class A Common Stock | 44,040 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-18 | Cavorsi Robert | 代扣税 (F) | Class A Common Stock | 5,487 | USD 3.84 | USD 21,070 | SEC 申报 ↗ |
| 2026-02-18 | Cavorsi Robert | 奖励／授予 (A) | Class A Common Stock | 16,454 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-18 | Bilbo Patrick | 代扣税 (F) | Class A Common Stock | 16,375 | USD 3.84 | USD 62,880 | SEC 申报 ↗ |
| 2026-02-18 | Bilbo Patrick | 奖励／授予 (A) | Class A Common Stock | 49,102 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-18 | Quintero Gilberto | 奖励／授予 (A) | Class A Common Stock | 48,828 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-18 | Montecalvo Antonio S. | 代扣税 (F) | Class A Common Stock | 3,741 | USD 3.84 | USD 14,365 | SEC 申报 ↗ |
| 2026-02-18 | Montecalvo Antonio S. | 奖励／授予 (A) | Class A Common Stock | 51,843 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-18 | Lustig Garrett | 奖励／授予 (A) | Class A Common Stock | 48,828 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-18 | Leibowitz Arthur S | 奖励／授予 (A) | Class A Common Stock | 48,828 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-18 | Korfin Michele Ilene | 奖励／授予 (A) | Class A Common Stock | 48,828 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-18 | Grow Brian | 代扣税 (F) | Class A Common Stock | 11,768 | USD 3.84 | USD 45,189 | SEC 申报 ↗ |
| 2026-02-18 | Grow Brian | 奖励／授予 (A) | Class A Common Stock | 282,705 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-18 | Gillheeney Gary S. | 代扣税 (F) | Class A Common Stock | 90,398 | USD 3.84 | USD 347,128 | SEC 申报 ↗ |
| 2026-02-18 | Gillheeney Gary S. | 奖励／授予 (A) | Class A Common Stock | 1,077,593 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-18 | Giacomin Jon L | 奖励／授予 (A) | Class A Common Stock | 48,828 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-18 | Freedman Lori | 代扣税 (F) | Class A Common Stock | 14,267 | USD 3.84 | USD 54,785 | SEC 申报 ↗ |
| 2026-02-18 | Freedman Lori | 奖励／授予 (A) | Class A Common Stock | 245,905 | USD 0.00 | USD 0 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | ORGO |
| CIK | 0001661181 |
| 行业 | Healthcare |
| 细分行业 | Drug Manufacturers—Specialty & Generic Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 433 transaction lines from 2020-01-21 to 2026-03-09 46 P purchase lines · 83 S sale lines · 304 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.